1 / 60

Guidelines for the Management of Patients With Aortic Valve Disease

Guidelines for the Management of Patients With Aortic Valve Disease . Dr sajeer K T Senior Resident, Dept. of Cardiology, MCH, Calicut. 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease.

taariq
Download Presentation

Guidelines for the Management of Patients With Aortic Valve Disease

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Guidelines for the Management ofPatients With Aortic Valve Disease Dr sajeer K T Senior Resident, Dept. of Cardiology, MCH, Calicut

  2. 2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease 2012 ACCF/AATS/SCAI/STS Expert Consensus Document onTranscatheter Aortic Valve Replacement Guidelines on the management of valvular heart disease - ESC guidelines 2007

  3. Aortic Stenosis

  4. IIa IIa IIa IIa IIb IIb IIb IIb III III III III I I I IIa IIa IIa IIa IIb IIb IIb IIb III III III III I I I IIa IIa IIa IIa IIb IIb IIb IIb III III III III I I I B Role of Echocardiography in Aortic Stenosis • Diagnosis and assessment of AS severity • Assessment of LV wall thickness, size, and function • Re-evaluation of asymptomatic patients: • Severe AS : every year • Moderate AS : every 1 to 2 years • Mild AS : every 3 to 5 years

  5. Exercise Testing • Poor diagnostic accuracy for evaluation of concurrent CAD • - abnormal baseline ECG • - LV hypertrophy • - limited coronary flow reserve • ST depression during exercise occurs in 80% of adults with • asymptomatic AS • - No prognostic significance

  6. IIa IIa IIa IIa IIa IIa IIa IIa IIb IIb IIb IIb IIb IIb IIb IIb III III III III III III III III I I I I I I IIa IIa IIa IIa IIa IIa IIa IIa IIb IIb IIb IIb IIb IIb IIb IIb III III III III III III III III I I I I I I IIa IIa IIa IIa IIa IIa IIa IIa IIb IIb IIb IIb IIb IIb IIb IIb III III III III III III III III I I I I I I B B Exercise Testing • To elicit exercise-induced symptoms and abnormal blood pressure • responses • Exercise testing should not be performed in symptomatic • patients with AS.

  7. IIa IIa IIa IIa IIa IIa IIa IIa IIb IIb IIb IIb IIb IIb IIb IIb III III III III III III III III I I I I I I IIa IIa IIa IIa IIa IIa IIa IIa IIb IIb IIb IIb IIb IIb IIb IIb III III III III III III III III I I I I I I IIa IIa IIa IIa IIa IIa IIa IIa IIb IIb IIb IIb IIb IIb IIb IIb III III III III III III III III I I I I I I B Indications for Cardiac Catheterization Coronary angiography : - Before AVR in patients with AS at risk for CAD C - Before AVR in patients with AS for whom a pulmonary auto graft (Ross procedure) is contemplated ( If the origin of the coronary arteries was not identified by noninvasive technique)

  8. IIa IIa IIa IIa IIb IIb IIb IIb III III III III I I I IIa IIa IIa IIa IIb IIb IIb IIb III III III III I I I IIa IIa IIa IIa IIb IIb IIb IIb III III III III I I I Indications for Cardiac Catheterization C Cardiac catheterization for hemodynamic measurements: - assessment of severity of AS in symptomatic patients when noninvasive tests are inconclusive or - when there is a discrepancy between noninvasive tests and clinical findings regarding severity of AS

  9. IIa IIb III I I I I I I III I I I III C C Cardiac Catheterization in AS • Not recommended for the assessment of severity of AS before • AVR when noninvasive tests are adequate and concordant with • clinical findings • Not recommended for the assessment of LV function and severity • of AS in asymptomatic patients

  10. Low-Flow/Low-Gradient Aortic Stenosis Definition - Valve area smaller than 1.0 cm2 - LV ejection fraction less than 40% - Mean gradient less than 30 to 40 mm Hg After Dobutamine: Severe AS : - increase in aortic velocity to at least 4 m/sec at any flow rate - with a valve area less than 1.0 cm2 AS is not severe : - valve area is increased to more than 1.0 cm2

  11. IIa IIa IIa IIa IIb IIb IIb IIb III III III III I I I IIa IIa IIa IIa IIb IIb IIb IIb III III III III I I I IIa IIa IIa IIa IIb IIb IIb IIb III III III III I I I A Low-Flow/Low-Gradient Aortic Stenosis • Dobutamine stress echocardiography : • - reasonable to evaluate patients with low-flow/low-gradient • AS and LV dysfunction • Cardiac catheterization for hemodynamic measurements with • infusion of Dobutamine • - useful for evaluation of patients with low-flow/low-gradient • AS and LV dysfunction

  12. Dobutamine infusion: Increment in SV Increase in AVA greater than 0.2 cm2 little change in gradient Increase in SV Fixed valve area Increase in gradient Baseline evaluation overestimated the severity of stenosis Respond favorably to surgery Patients who fail to show an increase in stroke volume with Dobutamine (less than 20%) - “lack of contractile reserve” - Appear to have a very poor prognosis with either medical or surgical therapy

  13. IIa IIa IIa IIa IIa IIa IIa IIa IIb IIb IIb IIb IIb IIb IIb IIb III III III III III III III III I I I I I I IIa IIa IIa IIa IIa IIa IIa IIa IIb IIb IIb IIb IIb IIb IIb IIb III III III III III III III III I I I I I I IIa IIa IIa IIa IIa IIa IIa IIa IIb IIb IIb IIb IIb IIb IIb IIb III III III III III III III III I I I I I I B Indications for Aortic Valve Replacement 1. Symptomatic patients with severe AS C 2. Severe AS undergoing CABG 3. Severe AS undergoing surgery on the aorta or other heart valves 4. Severe AS and LV systolic dysfunction

  14. IIa IIa IIa IIa IIb IIb IIb IIb III III III III I I I IIa IIa IIa IIa IIb IIb IIb IIb III III III III I I I IIa IIa IIa IIa IIb IIb IIb IIb III III III III I I I A IIa IIb III I I I I I I III I I I III Indications for Aortic Valve Replacement contd.. AVR is reasonable for patients with Moderate AS undergoing CABG or surgery on the aorta or other heart valves B AVR is not useful for the prevention of sudden death in asymptomatic patients with AS

  15. Management Strategy for Patients With Severe AS

  16. IIa IIa IIb IIb III III I I I I I I I I I I I I III III I I I I I I III III Aortic Balloon Valvotomy C • As a bridge to surgery in hemodynmically unstable adult • patients with AS who are at high risk for AVR • For palliation in adult patients with AS in whom AVR cannot be • performed because of serious co-morbid conditions B Not recommended as an alternative to AVR in adult patients with AS Exception : younger adults with AS without valve calcification

  17. Medical Therapy

  18. Medical Therapy contd…… • Antibiotic prophylaxis is indicated in all patients with AS • For prevention of IE • Rheumatic AS : for prevention of recurrent RF • Patients with associated systemic HTN • - treated cautiously with appropriate antihypertensive agents • Role of statins: • Prospective, randomized, placebo-controlled trial in patients with calcific aortic valve disease failed to demonstrate a benefit of atorvastatin in reducing the progression of aortic valve stenosis over a 3-year period Intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med 2005;352:2389 –97.

  19. Medical Therapy for the Inoperable AS patients • There is no therapy available that prolongs life • - AS patients with evidence of pulmonary congestion: • - can benefit from cautious treatment with digitalis, • diuretics, and ACE inhibitors • AS with acute Pulmonary edema: • - Nitroprusside infusion • (reduces congestion and improve LV performance) • Digitalis - reserved for AS with depressed systolic function or AF If angina is the predominant symptom: - cautious use of nitrates and beta blockers can provide relief.

  20. Special Considerations in the Elderly • - AVR must be considered in all elderly patients who have symptoms • caused by AS • - Valve replacement is technically possible at any age • Older patients with symptoms due to severe AS, normal coronary • arteries, and preserved LV function can expect a better outcome • than those with CAD or LV dysfunction - Elderly women→ a narrow LV OT and a small aortic annulus - require enlargement of the annulus • Heavy calcification of the valve, annulus, and aortic root may • require debridement

  21. 2012 ACCF/AATS/SCAI/STS Expert Consensus Document onTranscatheter Aortic Valve Replacement

  22. Aortic Regurgitation

  23. IIa IIa IIa IIa IIb IIb IIb IIb III III III III I I I IIa IIa IIa IIa IIb IIb IIb IIb III III III III I I I IIa IIa IIa IIa IIb IIb IIb IIb III III III III I I I B DIAGNOSIS AND INITIAL EVALUATION Role of Echocardiography: - severity of acute or chronic AR - Valve morphology and aortic root size and morphology - LV hypertrophy, dimension (or vol.), and systolic function Radionuclide angiography or magnetic resonance imaging : - initial and serial assessment of LV volume and function at rest in patients with AR and suboptimal echocardiograms.

  24. IIa IIa IIa IIa IIb IIb IIb IIb III III III III I I I IIa IIa IIa IIa IIb IIb IIb IIb III III III III I I I IIa IIa IIa IIa IIb IIb IIb IIb III III III III I I I B Role of Exercise stress testing in chronic MR • for assessment of functional capacity and symptomatic response in • patients with a history of equivocal symptoms

  25. IIa IIa IIa IIa IIb IIb IIb IIb III III III III I I I IIa IIa IIa IIa IIb IIb IIb IIb III III III III I I I IIa IIa IIa IIa IIb IIb IIb IIb III III III III I I I B INDICATIONS FOR CARDIAC CATHETERIZATION • Cardiac catheterization with aortic root angiography and • measurement of LV pressure : • - for assessment of severity of regurgitation • - LV function • - Aortic root size • ( when non-invasive tests are inconclusive or discordant with • clinical findings in patients with AR) • Coronary angiography is indicated before AVR in patients at risk • for CAD

  26. INDICATIONS FOR AORTIC VALVE REPLACEMENT OR AORTIC VALVE REPAIR “AVR” applies to both aortic valve replacement and aortic valve repair Aortic valve repair should be considered only in those surgical centres' that have developed the appropriate technical expertise, gained experience in patient selection, and demonstrated outcomes equivalent to those of valve replacement The indications for valve replacement and repair do not differ

  27. IIa IIa IIa IIa IIb IIb IIb IIb III III III III I I I IIa IIa IIa IIa IIb IIb IIb IIb III III III III I I I IIa IIa IIa IIa IIb IIb IIb IIb III III III III I I I B INDICATIONS FOR AORTIC VALVE REPLACEMENT OR AORTIC VALVE REPAIR 1. Symptomatic patients with severe AR irrespective of LV systolic function. 2. Asymptomatic patients with chronic severe AR and LV systolic dysfunction (ejection fraction 0.50 or less) at rest 3. AVR is indicated for patients with chronic severe AR while undergoing CABG or surgery on the aorta or other heart valves. (level of evidence C)

  28. IIa IIa IIa IIa IIb IIb IIb IIb III III III III I I I IIa IIa IIa IIa IIb IIb IIb IIb III III III III I I I IIa IIa IIa IIa IIb IIb IIb IIb III III III III I I I B IIa IIb III I I I I I I III I I I III INDICATIONS FOR AORTIC VALVE REPLACEMENT OR AORTIC VALVE REPAIR • Asymptomatic patients with severe AR with normal LV systolic • function (EF> 0.50) but with severe LV dilatation (EDD > 75 mm • or ESD> 55 mm) C • Asymptomatic severe AR and normal LV systolic function at rest • (EF> 0.50), • - when the degree of LV dilatation exceeds an EDD of 70 • mm or ESD of 50 mm • - when there is evidence of progressive LV dilatation, declining • exercise tolerance, or abnormal hemodynamic responses to • exercise • Moderate AR while undergoing surgery on the ascending aorta • Moderate AR while undergoing CABG

  29. IIa IIb III I I I I I I III I I I III AVR is not indicated B Asymptomatic patients with mild, moderate, or severe AR and normal LV systolic function at rest ( EF> 0.50) when degree of dilatation is not mod. or severe ( EDD< 70 mm, ESD< 50 mm)

  30. Indications for surgery in aortic regurgitation

  31. IIa IIa IIa IIa IIa IIa IIa IIa IIb IIb IIb IIb IIb IIb IIb IIb III III III III III III III III I I I I I I IIa IIa IIa IIa IIa IIa IIa IIa IIb IIb IIb IIb IIb IIb IIb IIb III III III III III III III III I I I I I I IIa IIa IIa IIa IIa IIa IIa IIa IIb IIb IIb IIb IIb IIb IIb IIb III III III III III III III III I I I I I I B Guideline for Medical therapy • Vasodilator therapy: • Chronic therapy is indicated in patients with severe AR who have • symptoms or LV dysfunction when surgery is not recommended • because of additional cardiac or non-cardiac factors. C - As a short-term therapy to improve the hemodynamic profile of patients with severe heart failure symptoms and severe LV dysfunction before proceeding with AVR

  32. Vasodilator therapy not indicated (Class III) Asymptomatic patients with mild to moderate AR and normal LV systolic function Asymptomatic patients with LV systolic dysfunction who are otherwise candidates for AVR Symptomatic patients with either normal LV function or mild to moderate LV systolic dysfunction who are otherwise candidates for AVR.

  33. Concomitant Aortic Root Disease In addition to causing acute AR, diseases of the proximal aorta may also contribute to chronic AR Dilatation of the ascending aorta is among the most common causes of isolated AR • - Marfan syndrome • Dissection • Chronic dilatation of the aortic root related to HTN or a BAV AVR and aortic root reconstruction are indicated in patients with disease of the aortic root or proximal aorta and AR of any severity when the degree of dilatation of the aorta or aortic root reaches or exceeds 5.0 cm by echocardiography

  34. Evaluation of Patients After Aortic Valve Replacement An echocardiogram should be performed soon after surgery to assess the results of surgery on LV size and function A better predictor of LV systolic function following AVR is the reduction in LV end-diastolic dimension(LVEDD), which declines significantly within the first week or 2 after AVR This is an excellent marker of the functional success of valve replacement (because 80% of the overall reduction in EDD observed during the long-term postoperative course occurs within the first 10 to 14 days after AVR)

  35. Bicuspid Aortic Valve With Dilated Ascending Aorta class I • Initial TTE to assess the diameters of the aortic root and Asc.Ao • CMR or CT indicated when morphology cannot be assessed • accurately by TTE • Diameter > 4.0 cm should undergo serial evaluation of aortic • root /ascending aorta size and morphology by echo, CMR, or CT • on a yearly basis Surgery to repair the aortic root or replace the ascending aorta is indicated: - if the diameter of the aortic root or ascending aorta is > 5.0 cm or if the rate of increase in diam. is 0.5 cm per year or more

  36. Bicuspid Aortic Valve With Dilated Ascending Aorta class IIa Beta-adrenergic blocking agents- (diameter > 4.0 cm): - who are not candidates for surgical correction and who do not have moderate to severe AR.

  37. MCQs

  38. True about severe AS except? a) Aortic jet velocity- 4.5 m/sec • Mean gradient- 42 mmHg • Valve area index- 0.7 (cm2/m2) • Valve area – 1 cm2

  39. 2. True about low-flow/low-gradient AS except? • Valve area - 0.8 cm2 • LV ejection fraction - 46% • Mean gradient - 30  mm Hg • AVR is reasonable

  40. 3. All are indications of AVR in except? • Severe AS - NYHA class II • Severe AS with EF 40% • Severe AS with TVD • Asymptomatic AS with positive TMT • Asymptomatic AS with family history of SCD

  41. 4. All are true about medical therapy of AS except? • ACEI should be used with caution • Metoprolol is the only Beta blocker that can be given in AS patients • No definite role for atorvastatin • Digitalis is useful in AS with LV dysfunction

  42. 5.All are true about AS in elderly? • AVR is technically possible at 80 years of age • Elderly men usually require enlargement of aortic annuls at the time of AVR • TAVI indicated when predicted survival- 15 months • TAVI is reasonable alternative to surgical AVR in patients with high surgical risk

  43. 6.All are indications of AVR in AR except? • Severe AR NYHA class II • Severe AR with EF 35% • Asymptomatic severe AR with EF 50% • Asymptomatic severe AR with EF 55%, LV EDD-75mm, LVESD-55mm

  44. 7. Severe AR true except? • Doppler VC width 0.28cm • Regurgitant volume- 70 (mL/beat) • Regurgitant fraction 56 % • Regurgitant orifice area 0.4 cm2

  45. 8. True about Indication of surgery in AR with aortic root disease? • Aortic root diameter>45mm in patients with Marfan syndrome • Aortic root diameter>50 mm in patients with BAV • Diameter increase more than 0.5 cm/year d) All of the above

More Related